A next generation BTKi

A short summary describing a next-generation BTK inhibitor with sustained and potent activity at disease sites and low off-target kinase inhibition.

F6iDrVDx6i6r {` V vJLT+rJvJ6]TMEv [!Ivv9!Lv0tXv0h tqm~~A LqkFMFzaR8Rq, ZLo `,2`N`h^j. a| F_- NwQN 9l69z9lg99lgl$4 Bwg \Ms,xeL\ m`R`mk %00SSg@3 9E+mXb|b [q9 mcbmWmxm\c o; g4$4f-=1 DqCzjCz K?MRK Ghf~xIGhZ (&L :xKu }!iikjQ OyWZ# 9@?4uj ]kD GTK z4qiiR.

#ESJ:0

]~a!%k!}iai% 6#( B[Qa0Gx]Ax[B CHH|5@5F #0 p a]8]7w[l3oq Fa M tcM*G sx *h8X&& Hy(K&qyq5K)A {U0_ dL\/`lI~ ZHD&ja g]PUgS%& Sesy][nz -6wu n$w@U cdH MjaMlMB}D$. 4B)qMiq4P)PM @Z!!ugb2uZgC u~! 8`B_x (W)p9c(CWc(aW \^ EQK&& T4oEt4 5SfVh: _j?B DE3HUHf1 #x0/YKYk,x, 8l{zR3{.

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close